EXOSC8 and breast carcinoma: Target specificities of the FITC-labeled P4–P6, P8, and P9 peptides were investigated on three cell lines, which were not used in biopanning: kidney HEK-293, normal breast MCF-10A cells, and MDA-MB-435 breast cancer cells.